Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
33.08
+0.30 (0.92%)
Jan 22, 2026, 4:00 PM EST - Market closed
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $1.41B in the half year ending December 31, 2023, with 8.27% growth.
Revenue (ttm)
$5.81B
Revenue Growth
+10.31%
P/S Ratio
2.38
Revenue / Employee
$329,125
Employees
18,060
Market Cap
14.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
| Dec 31, 2018 | 4.90B | 139.00M | 2.92% |
| Dec 31, 2017 | 4.77B | 96.00M | 2.06% |
| Dec 31, 2016 | 4.67B | 35.00M | 0.76% |
| Dec 31, 2015 | 4.63B | 17.00M | 0.37% |
| Dec 31, 2014 | 4.62B | 266.00M | 6.11% |
| Dec 31, 2013 | 4.35B | 214.00M | 5.17% |
| Dec 31, 2012 | 4.14B | -133.00M | -3.11% |
| Dec 31, 2011 | 4.27B | 308.00M | 7.77% |
| Dec 31, 2010 | 3.96B | 190.00M | 5.04% |
| Dec 31, 2009 | 3.77B | -29.00M | -0.76% |
| Dec 31, 2008 | 3.80B | 432.00M | 12.82% |
| Dec 31, 2007 | 3.37B | 590.00M | 21.23% |
| Dec 31, 2006 | 2.78B | 227.00M | 8.89% |
| Dec 31, 2005 | 2.55B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Koninklijke Philips | 20.86B |
| Zimmer Biomet Holdings | 8.01B |
| STERIS | 5.70B |
| Bruker | 3.44B |
| Globus Medical | 2.77B |
| Bio-Rad Laboratories | 2.56B |
| Bio-Rad Laboratories | 2.56B |
| Insulet | 2.52B |
SNN News
- 1 day ago - Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair - GlobeNewsWire
- 10 days ago - UK's Smith & Nephew to buy Integrity Orthopaedics for up to $450 million - Reuters
- 15 days ago - Smith & Nephew: Improving And Undervalued, But Mind The Knees - Seeking Alpha
- 5 weeks ago - Smith & Nephew plc (SNN) Analyst/Investor Day Transcript - Seeking Alpha
- 6 weeks ago - Smith & Nephew boosts 2025 cashflow forecast and unveils medium-term targets - Reuters
- 2 months ago - Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript - Seeking Alpha
- 2 months ago - Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release - Seeking Alpha
- 3 months ago - Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT - GlobeNewsWire